LifeWIRE's mHEALTH platform received FDA ePRO Validation

A belated very Happy New Year!

As a quick beginning of the year update, we are very excited to announce that LifeWIRE's mHealth communication platform has just received the FDA's ePRO validation (under FDA 21 CFR Part 11). What that means is that  LifeWIRE messaging interactions are considered by the FDA as the equivalent of paper records/signatures and may be used in lieu of paper records for any valiadtion required by our clients. The ePRO process, which commenced in May 2012 and was completed just days ago, allowed us to affirm the robustness of the platform as well as our compliance in all manner of security and privacy. All this and we continue to attain very high levels of engagement with patient/users.

In related news, we are also excited to have had our third co-authored paper published in this past 4 week period (these papers are noted below with links to the documents). The papers range from a peer reviewed study on the use of LifeWIRE in PTSD published in the UK, to a mobile health strategy paper published by HIMSS, and a provincial government strategy paper on the mobile industry in Ontario (where our contribution concentrated on Chairing/authoring the mobile health section).

Say tuned for many more announcement and updates in the near future

All the very best of the New year,

Co-Authored peer Reviewed Study on the Use of LifeWIRE with Wounded Warriors suffering from PTSD

Co-Authored the mHIMSS Roadmap to provide guidance on the adoption of mHealth solutions
One of the Primary Researchers/
Contributors on a provincial strategy paper on the mobile industry 
Copyright © 2013 LifeWIRE Corp, All rights reserved.
unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp